For example, PLGA nanoparticles encapsulating STING agonists (e.g., ONP-302) in PBMC-engrafted NSG mice elicit IL-15–dependent activation of human NK cells and CD8+ T cells, demonstrating significant tumour growth suppression and translational relevance (37). This evidence concerns the gene STING1 and neoplasm.